WE ARE AMONG TURKEY'S TOP 250 COMPANIES IN 2023 BASED ON R&D EXPENDITURES!

WE ARE AMONG TURKEY'S 500 LARGEST INDUSTRIAL ENTERPRISES IN 2023

WE HAVE RECEIVED OUR 3RD MARKETING AUTHORIZATION FROM THE UK HEALTH AUTHORITY (MHRA)

'RESPECT FOR PEOPLE AWARD' FROM KARIYER.NET TO POLİFARMA IN 2022 AND 2023

POLİFARMA RECEIVES TWO POSTER AWARDS AT THE 11TH INTERNATIONAL CONGRESS OF MEDICINAL CHEMISTRY

AWARD FOR "BEST IN-HOUSE TRAINING OF THE YEAR" FROM THE GOLDEN PULSE AWARDS

INCENTIVE AWARD FOR THE "EARTHQUAKE SHIELD IN INDUSTRY" PROJECT

WE ARE AMONG TURKEY'S LARGEST COMPANIES ACCORDING TO THE 2022 TURKISHTIME R&D 250 RESEARCH

WE ARE AMONG TURKEY'S TOP 500 INDUSTRIAL ENTERPRISES

WE HAVE RECEIVED OUR ZERO WASTE CERTIFICATE

ACCORDING TO 2022 İKMİB DATA, WE RANK 15TH IN THE PHARMACEUTICAL EXPORT CATEGORY

WE HAVE RECEIVED GMP (GOOD MANUFACTURING PRACTICE) CERTIFICATION FROM THE THERAPEUTIC GOODS ADMINISTRATION (TGA) OF AUSTRALIA FOR POLİFARMA AND AIS PRODUCTION FACILITIES

POLİFARMA RECEIVES THE 'MOST INNOVATIVE PHARMACEUTICAL COMPANY IN R&D' AWARD FROM GLOBAL BUSINESS OUTLOOK AWARDS

GOLDEN CRUCIBLE AWARD IN THE "INVESTMENT" CATEGORY GOES TO POLİFARMA

WE ARE AMONG TURKEY'S TOP 250 COMPANIES IN 2023 BASED ON R&D EXPENDITURES!

WE ARE AMONG TURKEY'S 500 LARGEST INDUSTRIAL ENTERPRISES IN 2023

WE HAVE RECEIVED OUR 3RD MARKETING AUTHORIZATION FROM THE UK HEALTH AUTHORITY (MHRA)

'RESPECT FOR PEOPLE AWARD' FROM KARIYER.NET TO POLİFARMA IN 2022 AND 2023

POLİFARMA RECEIVES TWO POSTER AWARDS AT THE 11TH INTERNATIONAL CONGRESS OF MEDICINAL CHEMISTRY

AWARD FOR "BEST IN-HOUSE TRAINING OF THE YEAR" FROM THE GOLDEN PULSE AWARDS

INCENTIVE AWARD FOR THE "EARTHQUAKE SHIELD IN INDUSTRY" PROJECT

WE ARE AMONG TURKEY'S LARGEST COMPANIES ACCORDING TO THE 2022 TURKISHTIME R&D 250 RESEARCH

WE ARE AMONG TURKEY'S TOP 500 INDUSTRIAL ENTERPRISES

WE HAVE RECEIVED OUR ZERO WASTE CERTIFICATE

ACCORDING TO 2022 İKMİB DATA, WE RANK 15TH IN THE PHARMACEUTICAL EXPORT CATEGORY

WE HAVE RECEIVED GMP (GOOD MANUFACTURING PRACTICE) CERTIFICATION FROM THE THERAPEUTIC GOODS ADMINISTRATION (TGA) OF AUSTRALIA FOR POLİFARMA AND AIS PRODUCTION FACILITIES

POLİFARMA RECEIVES THE 'MOST INNOVATIVE PHARMACEUTICAL COMPANY IN R&D' AWARD FROM GLOBAL BUSINESS OUTLOOK AWARDS

GOLDEN CRUCIBLE AWARD IN THE "INVESTMENT" CATEGORY GOES TO POLİFARMA